By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical And Preclinical Data At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics Meeting 10/30/2014 10:54:41 AM
Loxo Oncology (LOXO) To Present Pre-Clinical Data On LOXO-101 At Upcoming European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 10/30/2014 10:15:20 AM
Sofie Biosciences Receives $1.5M National Cancer Institute Phase 2 SBIR 10/16/2014 7:26:47 AM
Actinobac Biomed, Inc. Receives $905,000 Small Business Grant From National Cancer Institute To Advance Blood Cancer Research 10/14/2014 1:17:06 PM
Drinking Coffee May Be Good For The Liver, National Cancer Institute Study 10/9/2014 3:05:33 PM
Intensity Therapeutics, Inc.'s Research Selected For Presentation At The Annual National Cancer Institute Cancer Immunology And Immunotherapy Conference 10/9/2014 10:44:05 AM
Blaze Bioscience Inc. Announces National Cancer Institute SBIR Phase II Funding For Clinical Trial Of Tumor Paintâ„¢ BLZ-100 In Sarcoma 10/8/2014 10:10:04 AM
Advanced Cell Diagnostics, Inc. Awarded $1.4 Million National Cancer Institute Grant To Develop Ultrasensitive Diagnostic Test For B-Cell Lymphoma 10/7/2014 8:43:46 AM
National Cancer Institute Awards Kiyatec Nearly $2 Million To Advance Predictive Cancer Diagnostics 9/18/2014 10:14:43 AM
Enumeral Biomedical (ENUM) Awarded Phase II SBIR Contract From The National Cancer Institute To Advance Human Tissue Immuno-Oncology Profiling 9/17/2014 10:46:46 AM
12345678910...
//-->